Hillsdale Investment Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-248,612
Closed -$1.51M 680
2020
Q3
$1.51M Sell
248,612
-90,500
-27% -$691K 0.15% 160
2020
Q2
$3.01M Buy
+339,112
New +$2.92M 0.27% 109
2019
Q2
Sell
-63,400
Closed -$399K 687
2019
Q1
$399K Hold
63,400
0.04% 364
2018
Q4
$411K Buy
+63,400
New +$485K 0.05% 311
2016
Q2
Sell
-6,800
Closed -$95K 576
2016
Q1
$95K Buy
+6,800
New +$70.4K 0.03% 310

Other funds holding NPTN

Hillsdale Investment Management's NPTN Position: Q4 2020 in Review

Hillsdale Investment Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 248,612 shares — an estimated $1.51M sold.

Hillsdale Investment Management first reported a position in NPTN in Q1 2016 and held it in 5 quarters. The position peaked at $3.01M in Q2 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Hillsdale Investment Management reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 248,612 NEOPHOTONICS CORP shares in Q4 2020, an estimated $1.51M.
  • Hillsdale Investment Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 5 quarters.
  • Hillsdale Investment Management's NEOPHOTONICS CORP position peaked at $3.01M in Q2 2020.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Hillsdale Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.